| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,295 |
22,558 |
$925K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,031 |
7,388 |
$408K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
35,963 |
13,009 |
$383K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,697 |
4,579 |
$373K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,559 |
3,460 |
$297K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,471 |
3,312 |
$266K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,333 |
2,256 |
$208K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13,846 |
11,698 |
$80K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,697 |
2,546 |
$62K |
| 92552 |
|
7,071 |
6,747 |
$61K |
| 90461 |
|
9,968 |
7,874 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
902 |
817 |
$43K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,920 |
1,826 |
$26K |
| 99429 |
|
824 |
788 |
$26K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
132 |
131 |
$18K |
| 99381 |
|
219 |
216 |
$18K |
| 99000 |
|
1,625 |
1,497 |
$17K |
| 99253 |
|
214 |
180 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
502 |
482 |
$13K |
| 83655 |
|
1,164 |
1,117 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
221 |
215 |
$10K |
| 0071A |
|
238 |
229 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
804 |
783 |
$8K |
| 0072A |
|
185 |
179 |
$8K |
| 99383 |
|
81 |
79 |
$7K |
| 0002A |
|
180 |
175 |
$6K |
| 0001A |
|
189 |
188 |
$6K |
| 99382 |
|
49 |
48 |
$4K |
| 99384 |
|
30 |
29 |
$3K |
| 99460 |
|
45 |
44 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
43 |
42 |
$3K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
284 |
256 |
$2K |
| 85018 |
|
2,688 |
2,558 |
$2K |
| 96160 |
|
723 |
677 |
$1K |
| 54150 |
|
12 |
12 |
$1K |
| 99406 |
|
1,170 |
1,101 |
$691.37 |
| 97803 |
|
7,768 |
7,487 |
$381.07 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
42 |
$162.51 |
| 90688 |
|
1,428 |
1,402 |
$1.79 |
| 90619 |
|
72 |
72 |
$0.46 |
| 90686 |
|
2,366 |
2,323 |
$0.09 |
| 90715 |
|
532 |
517 |
$0.03 |
| 90734 |
|
1,096 |
1,064 |
$0.01 |
| 90633 |
|
2,389 |
2,330 |
$0.01 |
| 90670 |
|
3,572 |
3,458 |
$0.01 |
| 90651 |
|
1,583 |
1,536 |
$0.01 |
| 99072 |
|
13,576 |
12,373 |
$0.00 |
| 99173 |
|
7,334 |
6,905 |
$0.00 |
| 90648 |
|
3,468 |
3,382 |
$0.00 |
| 90710 |
|
133 |
125 |
$0.00 |
| 91300 |
|
483 |
409 |
$0.00 |
| 90700 |
|
862 |
844 |
$0.00 |
| 90707 |
|
1,803 |
1,750 |
$0.00 |
| 90621 |
|
47 |
47 |
$0.00 |
| 90713 |
|
31 |
31 |
$0.00 |
| 91308 |
|
16 |
13 |
$0.00 |
| 90680 |
|
2,162 |
2,114 |
$0.00 |
| 90677 |
|
853 |
848 |
$0.00 |
| 90723 |
|
2,332 |
2,274 |
$0.00 |
| 90698 |
|
607 |
597 |
$0.00 |
| 90696 |
|
718 |
693 |
$0.00 |
| 90744 |
|
257 |
255 |
$0.00 |
| 90716 |
|
1,820 |
1,768 |
$0.00 |
| 91307 |
|
531 |
477 |
$0.00 |
| 90381 |
|
14 |
14 |
$0.00 |
| 90674 |
|
46 |
45 |
$0.00 |